S&P 500 Healthcare Sector SEC Filings — May 21, 2026

USA S&P 500 Healthcare

By Gunpowder Editorial ·

8 high priority 24 medium priority 32 total filings analysed

Executive Summary

The 32 filings in this S&P 500 Healthcare stream reveal a sector in transition, with strong operational performance at firms like Cirrus Logic (revenue +5.3% YoY, net income +25%) contrasting with acute distress at Dalrada Technology (revenue -44% YoY, negative equity).

Capital allocation is active: News Corp authorized a $1B buyback, Broadridge raised its dividend, and Medallion Financial highlighted record earnings amid a proxy fight. M&A activity is notable with Columbia Financial/Northfield Bancorp merger and Greenland Mines' $35M acquisition. Insider trading is sparse, but the proxy contest at Medallion and withheld votes at Kingsway and HBT Financial signal governance concerns. Forward-looking catalysts include Jupiter Neurosciences' $2M offering for Parkinson's trial and NanoViricides' Ebola commentary. Overall, the sector shows bifurcation between profitable incumbents and cash-burning biotechs, with regulatory and shareholder activism risks.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 10-K · DEFA14A · 8-K · 13F · 10-Q · DEFM14A · 425

Tracking the trend? Catch up on the prior S&P 500 Healthcare Sector SEC Filings digest from May 20, 2026.

Investment Signals (10)

  • Revenue +5.3% YoY to $1,997.4M, net income +25% to $414.4M, operating margin improved to 23% from 22%, cash flow from operations surged 46.4% to $650.6M, and share buybacks increased to $280M from $261M

  • Record earnings over last 5 years exceeding first 25 years as public company, independent analysts have BUY rating, $75M capital raise rated A- by Egan-Jones, but facing proxy fight from ZimCal

  • Declared quarterly dividend of $0.975 per share, payable July 2, 2026, indicating strong cash flow and shareholder return commitment

  • News Corp (BULLISH)

    Authorized up to $1B stock repurchase program for Class A and B shares, signaling confidence in valuation and commitment to returning capital

  • Raised $2M via registered direct offering of 7.14M shares at ~$0.28/share, lead program JOTROL in Phase IIa for Parkinson's, but offering is dilutive

  • Greenland Mines (Klotho Neurosciences) (BEARISH)

    Acquiring Neo North Star Resources for $35M ($20M cash + $15M stock), tax-free reorganization, but company has no revenue and is pivoting from biotech to mining

  • All director nominees elected with >82M votes for, executive compensation approved with 83M for vs 1M against, strong shareholder support

  • All proposals passed with strong support, Associate Stock Purchase Plan approved with 307M for vs 6.8M against, indicating shareholder confidence

  • All directors elected, auditor ratified with 74.8M for vs 1M against, though director Verity had 9.3M withheld votes

  • Declared Q3 FY2026 cash dividend, continuing shareholder return program

Risk Flags (8)

  • Dalrada Technology [HIGH RISK]

    Revenue declined 44% YoY to $2.6M, net loss of $4.3M flat vs prior year, cash fell 52% to $82.6K, negative equity of -$20.8M, total liabilities $38.5M vs current assets $8.0M

  • Two directors received significant withheld votes (23.7% and 22.6%), indicating notable shareholder dissent on governance

  • HBT Financial [LOW RISK]

    Director Roger A. Baker received 4.4M withheld votes (15.1% of votes cast), suggesting shareholder concerns

  • Say-on-Pay vote had 1.5M shares against and 112K abstentions, indicating some shareholder dissent on executive compensation

  • NanoViricides [MODERATE RISK]

    President claimed NV-387 and remdesivir combo effective against Ebola, but remdesivir efficacy not established in prior human trials, no clinical data provided

  • Dilutive offering of 7.14M shares at ~$0.28/share, no revenue, clinical-stage biotech with high cash burn

  • Greenland Mines (Klotho Neurosciences) [HIGH RISK]

    Pivoting from biotech to mining, no revenue, $35M acquisition financed with cash and stock, subject to Greenland government approval

  • Medallion Financial [MODERATE RISK]

    Proxy fight from debt holder ZimCal, board claims ZimCal lacks understanding of business, could distract management

Opportunities (8)

  • Cirrus Logic (OPPORTUNITY)

    Strong cash flow generation ($650.6M), increased buybacks ($280M), improving margins (23% vs 22% prior year), trading at reasonable valuation for growth

  • Medallion Financial (OPPORTUNITY)

    Record earnings, BUY rating from analysts, investment grade capital raise, potential resolution of proxy fight could unlock value

  • Merger vote scheduled June 25, 2026, support agreements from board members representing 4% voting power, potential synergies

  • Consistent dividend growth, strong cash flows, shareholder-friendly capital allocation

  • News Corp (OPPORTUNITY)

    $1B buyback authorization provides downside support, potential catalyst if repurchases accelerate

  • Voya Financial (OPPORTUNITY)

    Strong shareholder support for management, stable governance, potential for continued operational improvement

  • Genworth Financial (OPPORTUNITY)

    Strong shareholder approval for all proposals, including equity plan, indicating alignment

  • BayFirst Financial (OPPORTUNITY)

    New CEO Alfred Rogers brings extensive experience (grew USAmeriBank to $4.6B assets), potential turnaround catalyst

Sector Themes (5)

  • Bifurcation in Financial Health

    Profitable firms like Cirrus Logic (net income +25%) and Broadridge (dividend increase) contrast with distressed Dalrada (revenue -44%, negative equity). Investors should favor cash-rich companies.

  • Active M&A and Restructuring

    Columbia Financial/Northfield Bancorp merger, Greenland Mines acquisition of Neo North Star, and Klotho Neurosciences pivot to mining indicate sector consolidation and strategic shifts.

  • Shareholder Activism and Governance Scrutiny

    Medallion Financial proxy fight, withheld votes at Kingsway (23.7%) and HBT Financial (15.1%) highlight growing shareholder activism in financials.

  • Capital Allocation Focus

    News Corp ($1B buyback), Cirrus Logic ($280M buyback), and Broadridge (dividend) show strong return of capital, while Dalrada and Jupiter Neurosciences rely on dilutive financing.

  • Clinical-Stage Biotech Risks

    NanoViricides and Jupiter Neurosciences have no approved products or revenue, relying on early-stage trials and speculative statements, posing high risk for investors.

Watch List (8)

  • Proxy fight outcome and annual meeting results, watch for resolution or escalation [ongoing]

  • Merger vote on June 25, 2026, watch for approval and integration updates

  • JOTROL Phase IIa Parkinson's trial results, potential catalyst if positive [no date]

  • Any clinical data on NV-387 for Ebola or Mpox, watch for updates from DRC site [no date]

  • Greenland Mines (Klotho Neurosciences)
    👁

    Closing of Neo North Star acquisition and Greenland government approval [no date]

  • Dalrada Technology
    👁

    Liquidity crisis, watch for bankruptcy or restructuring, cash burn rate critical [imminent]

  • Integration planning updates, acquisition expected to close H2 2026

  • Next earnings report to see if margin improvement and cash flow growth continue [no date]

Filing Analyses (32)
CIRRUS LOGIC, INC. 10-K positive materiality 8/10

21-05-2026

Cirrus Logic reported strong financial results for fiscal year 2026, with net sales increasing 5.3% YoY to $1,997.4M and net income rising 25.0% to $414.4M, driven by improved gross margins and operating leverage. However, the company experienced a decline in inventories (down 19.5% to $240.9M) and a reduction in diluted EPS growth to $7.85 from $6.00, while cash flow from operations surged 46.4% to $650.6M.

  • · Operating income margin improved to 23% in FY2026 from 22% in FY2025 and 19% in FY2024.
  • · Net cash provided by operating activities increased 46.4% to $650.6M in FY2026 from $444.4M in FY2025.
  • · The company repurchased $280.0M of common stock in FY2026, up from $261.0M in FY2025.
  • · Cash and cash equivalents rose 48.5% to $800.9M at year-end.
  • · Inventories decreased 19.5% to $240.9M, reflecting improved inventory management.
  • · Prepaid wafers declined sharply from $52.6M to $14.7M (current) and from $15.5M to $0 (long-term).
  • · Total assets grew 7.0% to $2,489.4M.
  • · Stockholders' equity increased 9.2% to $2,128.0M.
  • · The effective tax rate decreased to 16.6% in FY2026 from 25.5% in FY2025.
  • · Basic weighted average shares outstanding declined 3.8% to 51.1M due to share repurchases.
MEDALLION FINANCIAL CORP DEFA14A mixed materiality 8/10

21-05-2026

Medallion Financial Corp. filed a definitive proxy statement for its 2026 Annual Meeting, urging shareholders to read all relevant documents. The company highlights a successful transformation from taxi medallion lending to consumer finance, with record earnings, loan growth, and shareholder returns. However, it faces a proxy fight from debt holder ZimCal, which the board claims lacks understanding of the business.

  • · Net income during the last 5 years exceeds the combined net income for first 25 years as a public company.
  • · Independent analysts have a BUY rating on Medallion stock.
  • · Latest $75M capital raise was rated A- by Egan-Jones (investment grade).
  • · Board has added three independent directors in the last 6 years and five in the last nine years.
  • · ZimCal is a debt holder vowing to wage proxy fights if not granted board seats or a profitable resolution to his debt position.
  • · ZimCal's nominees do not possess skills additive to the board according to the company.
NANOVIRICIDES, INC. 8-K neutral materiality 5/10

21-05-2026

NanoViricides, Inc. disclosed that its President and Executive Chairman, Dr. Anil R. Diwan, participated in the AGP Healthcare Companies Showcase on May 20, 2026, where he stated that the company's two drug candidates—NV-387 and NV-387 encapsulating Remdesivir—are expected to be effective against the current Ebola virus Bundibugyo strain in the DRC. The company has a clinical site in DRC for Mpox treatment, but no specific clinical data or timeline for Ebola was provided, and the efficacy of remdesivir against Ebola in prior human trials was not established.

  • · NV-387 is a broad-spectrum antiviral entering Phase II clinical trial against Mpox in DRC.
  • · NV-387 encapsulating Remdesivir is an oral formulation that protects remdesivir against bodily metabolism, as published in a peer-reviewed PLOS ONE paper.
  • · Remdesivir's efficacy against Ebola was not established in prior human clinical trials, but safety and tolerability were confirmed.
  • · The company has a clinical site in DRC for Mpox treatment.
JDM Financial Group LLC 13F-HR neutral materiality 5/10

21-05-2026

JDM Financial Group LLC filed its 13F-HR for the quarter ended March 31, 2026, reporting total holdings of approximately $259.35 million across 318 positions. The portfolio is heavily weighted toward ETFs, with top holdings including the Schwab U.S. Large-Cap ETF ($7,759 shares), Vanguard S&P 500 ETF ($300,823 shares), and iShares 0-3 Month Treasury Bond ETF ($283,950 shares), indicating a diversified, income-oriented strategy. However, the filing shows no period-over-period comparisons, so performance trends cannot be assessed.

  • · The portfolio includes 318 positions with a total market value of $259,352,536 as of March 31, 2026.
  • · Top holdings by share count include Schwab U.S. Large-Cap ETF (7,759 shares), Vanguard S&P 500 ETF (300,823 shares), iShares 0-3 Month Treasury Bond ETF (283,950 shares), and Vanguard Small-Cap ETF (94,414 shares).
  • · The filing does not provide prior period data, so no quarter-over-quarter or year-over-year comparisons are available.
  • · The portfolio contains a mix of U.S. and international equities, fixed-income ETFs, sector SPDRs, and alternative investments such as iShares Bitcoin Trust and Grayscale Bitcoin Mini Trust.
  • · Notable individual stock holdings include Amazon.com (2,608 shares), Microsoft (635 shares), NVIDIA (8,425 shares), and Meta Platforms (241 shares).
DALRADA FINANCIAL CORP 10-Q mixed materiality 9/10

21-05-2026

DALRADA TECHNOLOGY GROUP (DHTI) reported a net loss of $4.3M for the quarter ended March 31, 2026, roughly flat vs. a $4.2M loss in the same quarter last year, while total revenue declined 44% YoY to $2.6M. For the nine-month period, revenue fell 28% YoY to $9.9M, and the net loss improved 17% to $14.8M. The company continues to operate with negative stockholders' equity of -$20.9M and total current liabilities of $29.9M far exceed current assets of $8.0M, signaling acute liquidity risk.

  • · Cash and cash equivalents fell 52% from $172.8K at June 30, 2025 to $82.6K at March 31, 2026.
  • · Total liabilities increased 54% from $25.0M to $38.5M, driven by a surge in accounts payable and accrued liabilities – related parties (from $3.4M to $10.5M) and notes payable, current portion (from $3.9M to $9.1M).
  • · Stockholders' deficit worsened from -$6.7M to -$20.8M, more than tripling.
  • · Net cash used in operating activities for the nine months was $6.1M, roughly flat compared to $6.1M in the prior year period.
  • · Interest expense for the nine months increased 9.8% to $2.6M from $2.4M, while interest income dropped 91.2% to $5.1K.
  • · The company issued 14,206 shares of Series I preferred stock during Q1 FY2026 upon conversion of related party notes.
  • · Approximately $11.9M of preferred stock to be issued was reclassified to additional paid-in capital during the second quarter.
  • · Loss per share improved from -$0.19 to -$0.14 (basic and diluted) for the nine-month period.
NEWS CORP 8-K neutral materiality 5/10

21-05-2026

News Corp filed an 8-K on May 21, 2026, disclosing its ongoing stock repurchase program authorized for up to $1 billion in aggregate of Class A and Class B common stock. The filing includes daily transaction disclosures provided to the Australian Securities Exchange (ASX) as required by ASX rules. The company reaffirms its intent to repurchase shares from time to time, subject to market conditions and other factors.

  • · The repurchase program covers both Class A (NWSA) and Class B (NWS) common stock, each with a par value of $0.01 per share.
  • · The company is required to provide daily transaction disclosures to the ASX under ASX rules.
  • · The filing includes forward-looking statements regarding the company's intent to repurchase shares, subject to market price changes, general market conditions, securities laws, and alternative investment opportunities.
  • · The report was signed by Michael L. Bunder, Senior Vice President, Deputy General Counsel and Corporate Secretary.
Patriot Acquisition Corp./CI 8-K neutral materiality 6/10

21-05-2026

Patriot Acquisition Corp. closed the partial exercise of the underwriter's over-allotment option, selling an additional 1,500,000 units at $10.00 per unit for gross proceeds of $15,000,000, and simultaneously sold 75,000 additional private placement warrants for $75,000. Total gross proceeds from the IPO and over-allotment reached $175,000,000, with $175,875,000 now held in trust. The SPAC intends to focus on financial industry targets including fintech, specialty finance, and digital banking, but no business combination has been announced yet.

  • · The SPAC's management team is led by Jack Kopnisky (CEO/Chairman) and Thomas Cestare (CFO/Vice Chairman).
  • · The company intends to focus on the financial industry group (FIG Sector), specifically fee-based fintech, specialty finance, and digital banking.
  • · Units began trading on Nasdaq on May 15, 2026 under ticker PTACU.
  • · The registration statement was declared effective by the SEC on May 13, 2026.
  • · No business combination has been identified or announced; the company remains a blank check company.
KINGSWAY FINANCIAL SERVICES INC 8-K mixed materiality 6/10

21-05-2026

Kingsway Corporation held its 2026 annual meeting on May 18, 2026, with 73.09% of outstanding shares represented. Stockholders approved all five proposals, including the election of seven directors, ratification of Plante & Moran as auditor, a corporate name change, an increase in shares under the 2020 Equity Incentive Plan, and a nonbinding advisory vote on executive compensation. However, two directors—Gregory P. Hannon and Joseph D. Stilwell—received significant withheld votes (23.7% and 22.6% of votes cast, respectively), indicating notable shareholder dissent.

  • · Proposal 2 (ratification of auditor) passed with 21,121,851 votes for, 34,074 against, and 1,167 abstain.
  • · Proposal 3 (corporate name change) passed with 21,100,143 votes for, 44,542 against, and 12,407 abstain.
  • · Proposal 4 (equity plan amendment) passed with 13,079,270 votes for, 1,853,845 against, and 17,401 abstain, plus 6,206,576 broker non-votes.
  • · Proposal 5 (advisory vote on executive compensation) passed with 13,053,997 votes for, 1,887,562 against, and 8,957 abstain, plus 6,206,576 broker non-votes.
  • · The meeting was held on May 18, 2026, and the filing was made on May 21, 2026.
Voya Financial, Inc. 8-K positive materiality 3/10

21-05-2026

Voya Financial, Inc. held its Annual Meeting of Stockholders on May 21, 2026, where all twelve director nominees were elected, and stockholders approved, on an advisory basis, the compensation of named executive officers. Additionally, the appointment of Ernst & Young LLP as the independent auditor for fiscal year 2026 was ratified. All proposals received strong support, with no significant opposition or negative outcomes reported.

  • · All director nominees received over 82 million votes 'For', with the lowest being Hikmet Ersek at 82,351,013 votes.
  • · Advisory vote on executive compensation passed with 83,000,209 'For' votes against 1,056,471 'Against'.
  • · Ratification of Ernst & Young LLP as auditor for fiscal 2026 received 84,780,259 'For' votes, the highest support among all proposals.
  • · Broker non-votes totaled 3,466,146 for each director election and the advisory compensation vote, but were not applicable for the auditor ratification.
GENWORTH FINANCIAL INC 8-K positive materiality 3/10

21-05-2026

Genworth Financial held its 2026 annual meeting on May 20, 2026, where shareholders elected all ten director nominees, approved executive compensation on an advisory basis, approved the 2026 Associate Stock Purchase Plan, and ratified KPMG LLP as the independent auditor for 2026. All proposals passed with strong support, though director G. Kent Conrad received the lowest 'for' votes (300.3M) among nominees, and the advisory vote on executive compensation had 10.7M votes against.

  • · All ten director nominees were elected with 'for' votes ranging from 300.3M (Conrad) to 306.8M (Smith).
  • · The advisory vote on executive compensation received 303.2M for, 10.7M against, and 1.1M abstentions.
  • · The Associate Stock Purchase Plan was approved with 307.1M for, 6.8M against, and 1.1M abstentions.
  • · KPMG LLP was ratified as auditor with 333.2M for, 7.2M against, and 5.6M abstentions; no broker non-votes on this proposal.
  • · Broker non-votes totaled 30.9M for proposals 1-3.
CHEMUNG FINANCIAL CORP 8-K neutral materiality 3/10

21-05-2026

Chemung Financial Corporation declared a cash dividend of $0.34 per share, payable July 1, 2026, to shareholders of record as of June 17, 2026. The dividend was announced via a press release on May 21, 2026. No prior period comparison or financial performance data was provided in this filing.

  • · Dividend payable date: July 1, 2026
  • · Record date: June 17, 2026
  • · Common stock par value: $0.01 per share
  • · Trading symbol: CHMG on Nasdaq
Columbia Financial, Inc. DEFM14A neutral materiality 8/10

21-05-2026

Columbia Financial, Inc. filed a definitive proxy statement (DEFM14A) on May 21, 2026, for its annual meeting and a special meeting of Northfield Bancorp stockholders to approve their merger. The filing includes proposals for say-on-pay, say-on-pay frequency, and adjournment, with boards unanimously recommending 'FOR' votes. Northfield Bancorp stockholders will vote on the merger, merger-related compensation, and adjournment, with 41,763,852 shares outstanding as of the April 27, 2026 record date.

  • · Northfield Bancorp special meeting will be held virtually on June 25, 2026 at 9:00 a.m. Eastern time.
  • · Record date for Northfield Bancorp special meeting is April 27, 2026.
  • · Board members of Northfield Bancorp entered into support agreements to vote in favor of the merger, representing approximately 4.0% of voting power.
  • · Deadline for Northfield Bank ESOP and 401(k) Plan voting instructions is June 18, 2026 at 11:59 p.m. Eastern time.
  • · All three Northfield Bancorp proposals (merger, merger-related compensation, adjournment) are considered non-routine under NYSE rules.
CITIGROUP INC 8-K neutral materiality 3/10

21-05-2026

Citigroup Inc. filed an 8-K on May 21, 2026, covering director/officer departure or election matters (Items 5.02 and 5.07). The filing lists Citigroup's various securities registered under Section 12(b) of the Exchange Act, including common stock, depositary shares for preferred stock, trust preferred securities, and multiple series of medium-term senior notes. No financial results or period-over-period comparisons were provided in this filing.

  • · The 8-K covers Items 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers) and 5.07 (Submission of Matters to a Vote of Security Holders).
  • · Specific details on board changes or shareholder votes were not disclosed in this excerpt; the filing primarily contains the exhibit listing registered securities.
ONEOK INC /NEW/ 8-K neutral materiality 5/10

21-05-2026

ONEOK, Inc. held its Annual Meeting of Shareholders on May 20, 2026, where shareholders elected 10 director nominees, ratified PricewaterhouseCoopers LLP as independent auditor for FY2026, and approved a non-binding advisory vote on executive compensation. All three proposals were approved. The company is not an emerging growth company and its common stock trades on the NYSE under ticker OKE.

  • · Broker non-votes were approximately 104.1 million shares for director elections and the advisory compensation vote; no broker non-votes for auditor ratification.
  • · Proposal 1 (Director Election) – highest votes for: Mark A. McCollum (450,700,174 for); lowest votes for: Randall J. Larson (426,310,931 for).
  • · Proposal 2 (Auditor Ratification) – overwhelming approval with 551,715,532 votes for (98.6% of votes cast).
  • · Proposal 3 (Say-on-Pay) – approved with 428,986,336 votes for (94.3% of votes cast excluding broker non-votes).
  • · Definitive proxy statement was filed on April 1, 2026.
GCI Liberty, Inc. 8-K neutral materiality 3/10

21-05-2026

GCI Liberty, Inc. filed an 8-K on May 21, 2026, reporting amendments to its charter or bylaws (Item 5.03) and disclosing other material events (Item 7.01). The filing includes Exhibit 3.1, which appears to be a document related to the Secretary of State of Nevada, signed by Chief Legal Officer and Chief Administrative Officer Renee L. Wilm. No specific financial figures or period-over-period comparisons are provided in this filing.

  • · Filing includes Exhibit 3.1, which references the Secretary of State of Nevada (North Carson Street, Carson City, NV 89701-4201).
  • · The exhibit was signed by Renee L. Wilm, Chief Legal Officer and Chief Administrative Officer.
AMERICAN FINANCIAL GROUP INC 8-K positive materiality 3/10

21-05-2026

American Financial Group Inc. held its annual meeting on May 20, 2026, where all 12 director nominees were elected, Ernst & Young LLP was ratified as the independent auditor for 2026, and executive compensation was approved on an advisory basis. All proposals passed with strong shareholder support, though director William W. Verity received the highest number of withheld votes (9,337,468), indicating some shareholder dissent.

  • · Director William W. Verity received 62,988,078 votes for and 9,337,468 withheld, the highest withheld count among nominees.
  • · Director Roger K. Newport received the most votes for (72,097,586) and the fewest withheld (227,960).
  • · Ratification of Ernst & Young LLP passed with 74,822,879 votes for, 1,034,836 against, and 53,183 abstentions.
  • · Advisory vote on executive compensation passed with 69,738,224 for, 2,495,013 against, and 92,309 abstentions.
  • · Broker non-votes totaled 3,585,352 on director elections and the executive compensation proposal.
PATHWARD FINANCIAL, INC. 8-K neutral materiality 3/10

21-05-2026

Pathward Financial, Inc. announced a cash dividend for the third quarter of fiscal year 2026 on May 21, 2026. The filing does not specify the dividend amount or any other financial metrics, providing only the declaration event.

  • · The dividend is for the third quarter of fiscal year 2026.
  • · The press release is attached as Exhibit 99.1.
River Financial Corp 8-K positive materiality 3/10

21-05-2026

River Financial Corporation held its 2026 Annual Meeting on May 19, 2026, where all nine director nominees were re-elected. The voting results show strong support for each nominee, with votes for ranging from 4,138,962 to 4,154,632, and minimal votes against and abstentions.

  • · Broker non-votes ranged from 0 to 5,442 across nominees.
  • · Jerry C. Kyser, Jr. received the most votes against (16,112) and 2,500 abstentions.
  • · Larry Puckett, James M. Stubbs, and Brian McLeod had zero abstentions.
Klotho Neurosciences, Inc. 8-K neutral materiality 8/10

21-05-2026

On May 20, 2026, Greenland Mines Ltd (formerly Klotho Neurosciences, Inc., ticker GRML) entered into a definitive merger agreement to acquire Neo North Star Resources, Inc. for total consideration of $35,000,000, comprising $20,000,000 in cash and $15,000,000 in newly issued common stock. The transaction is subject to customary closing conditions and approval from the government of Greenland under section 69 of the Greenland Mineral Activities Act for the indirect transfer of mineral rights. However, the merger is structured as a tax-free reorganization and includes a $1,750,000 payment to AnorTech Inc. (5% of the purchase price) and a warrant held by Shenandoah Partners Management LLC that may be exercised before closing.

  • · The merger is intended to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code.
  • · The Shenandoah warrant has an exercise price of $1.50 per share and expires on April 20, 2033, or earlier at the Effective Time.
  • · The surviving corporation will be named Neo North Star Resources, Inc. and will be a wholly-owned subsidiary of Greenland Mines Ltd.
  • · The merger agreement includes customary representations and warranties and is subject to approval from the government of Greenland under section 69 of the Greenland Mineral Activities Act.
  • · The filing was made by Greenland Mines Ltd (formerly Klotho Neurosciences, Inc.), which changed its name from ANEW Medical, Inc. in June 2024 and from Redwoods Acquisition Corp. in January 2022.
BayFirst Financial Corp. 8-K neutral materiality 5/10

21-05-2026

BayFirst Financial Corp. received regulatory non-objection from the Federal Reserve Bank of Atlanta to appoint Alfred T. Rogers, Jr. as President, CEO, and board member, effective May 14, 2026. Mr. Rogers brings extensive banking experience, including leading USAmeriBank from de novo status to over $4.6 billion in assets. No financial results or period-over-period comparisons are included in this filing.

  • · Mr. Rogers began his banking career at First Union National Bank in 1987.
  • · He served as CEO of Manufacturers Bank of Florida and was instrumental in its sale to Colonial Bank in 2001.
  • · He joined USAmeriBank in 2007 as Executive Lending Officer and grew it to over $4.6 billion in assets.
  • · After USAmeriBank's acquisition by Valley National Bank in January 2018, he served as EVP and Chief Lending Officer for Florida and Alabama until retiring in August 2022.
BROADRIDGE FINANCIAL SOLUTIONS, INC. 8-K positive materiality 5/10

21-05-2026

Broadridge Financial Solutions declared a quarterly cash dividend of $0.975 per share, payable on July 2, 2026 to stockholders of record on June 12, 2026. The dividend represents a continuation of the company's shareholder return program.

  • · Dividend payable on July 2, 2026
  • · Record date: June 12, 2026
JUPITER NEUROSCIENCES, INC. 8-K neutral materiality 7/10

21-05-2026

Jupiter Neurosciences announced a registered direct offering of 7,142,858 shares of common stock, with gross proceeds of approximately $2.0 million. The offering is expected to close on May 21, 2026, with D. Boral Capital LLC acting as exclusive placement agent. The company is a clinical-stage biopharmaceutical firm with no disclosed revenue or profitability metrics, and the offering may dilute existing shareholders.

  • · The offering is conducted under an effective shelf registration statement on Form S-3 (Registration No. 333-295085), declared effective on April 24, 2026.
  • · The company's lead program JOTROL is in a Phase IIa clinical trial for Parkinson's disease.
  • · The company also commercializes Nugevia, a consumer longevity supplement, and has acquired U.S. rights to ALA-002, a next-generation psychedelic NCE.
Federal Home Loan Bank of New York 8-K neutral materiality 5/10

21-05-2026

Federal Home Loan Bank of New York issued six callable fixed-rate consolidated obligations on May 18-19, 2026, with total par value of $745,000,000. The bonds have maturities ranging from November 2026 to May 2031 and coupon rates between 3.8% and 4.75%. All bonds are classified as Optional Principal Redemption (callable) with Bermudan or European call styles.

  • · All bonds are fixed rate constant type.
  • · Call styles include Bermudan (redeemable on specified recurring dates) and European (redeemable on a particular date only).
  • · Next call dates range from August 2026 to May 2027.
  • · The bonds are issued under the Bank's consolidated obligations program.
Federal Home Loan Bank of San Francisco 8-K neutral materiality 5/10

21-05-2026

Federal Home Loan Bank of San Francisco filed an 8-K reporting the issuance of a consolidated obligation bond on May 19, 2026, with a principal amount of $15,000,000. The bond has a 4.875% fixed coupon, matures on May 27, 2031, and is callable on a Bermudan schedule starting November 27, 2026. The filing provides details on the Bank's funding through consolidated obligations, which are joint and several liabilities of the eleven Federal Home Loan Banks and are not guaranteed by the U.S. government.

  • · The bond has a CUSIP of 3130BAU4.
  • · Settlement date is May 27, 2026.
  • · Next pay date is November 27, 2026.
  • · Call type is Optional Principal Redemption (callable).
  • · Rate type is Fixed Constant.
  • · The filing notes that consolidated obligations are not guaranteed by the U.S. government.
Federal Home Loan Bank of Cincinnati 8-K neutral materiality 7/10

21-05-2026

On May 19, 2026, Federal Home Loan Bank of Cincinnati issued two Consolidated Bonds totaling $35,000,000 in par value. The bonds are non-callable with fixed coupon rates of 4.5% (due 2033) and 4.375% (due 2029). This offering is part of the FHLB's routine funding through Consolidated Obligations, which are joint and several liabilities of the 11 Federal Home Loan Banks and are not guaranteed by the U.S. government.

  • · The bonds are not guaranteed by the United States government.
  • · The bonds are joint and several obligations of the 11 Federal Home Loan Banks.
  • · Both bonds are classified as Fixed Constant Rate and are Non-Callable.
PSB Financial, Inc. 8-K neutral materiality 5/10

21-05-2026

PSB Financial, Inc. announced the closing of its subscription offering in connection with the conversion of Pioneer State Bank to a stock bank. The company's common stock is expected to begin quoting on the OTCQB Market under the symbol 'PNSB' on May 22, 2026.

  • · The press release was issued on May 21, 2026.
  • · The common stock will be quoted on the OTCQB Market, not a national exchange.
  • · The company is an emerging growth company as defined under SEC rules.
Federal Home Loan Bank of New York 8-K neutral materiality 3/10

21-05-2026

On May 21, 2026, the Federal Home Loan Bank of New York (FHLBNY) announced a dividend declaration by its Board of Directors for the quarter ended March 31, 2026, via a President's Report to members. The filing does not disclose the dividend amount or rate, nor any comparative performance data, limiting the ability to assess financial trends.

  • · The dividend is for the quarter ended March 31, 2026.
  • · The President's Report is attached as Exhibit 99.1.
  • · The filing was signed by Kevin M. Neylan, Senior Vice President and CFO.
BankChampaign, National Association 13F-HR neutral materiality 5/10

21-05-2026

BankChampaign, National Association filed its Form 13F-HR for the quarter ended March 31, 2026, disclosing 186 equity holdings with a total reported market value of approximately $100.8 million. The portfolio is diversified across sectors including technology, energy, healthcare, and industrials, with top holdings in Walmart, Caterpillar, Apple, and Microsoft. The filing reflects the bank's investment strategy as of the reporting date, with no prior-period comparison available.

  • · The filing was signed by Karen Sharp, Senior Vice President Wealth Management, on May 15, 2026.
  • · The portfolio includes 186 positions, with the largest single holding being Western Digital Corp at approximately $2.13 million.
  • · Other significant holdings include Royal Gold Inc ($2.07M), Pan American Silver Corp ($2.45M), and Palantir Technologies Inc ($2.28M).
  • · The filing is a 13F-HR for the quarter ended March 31, 2026, filed on May 21, 2026.
BankChampaign, National Association 13F-HR neutral materiality 5/10

21-05-2026

BankChampaign, National Association filed its quarterly 13F-HR report for the period ending December 31, 2025, disclosing holdings in 179 equity positions with a total market value of approximately $101.5M. The portfolio is heavily concentrated in common stocks of large-cap companies (Alphabet, Broadcom, NVIDIA, Apple, Microsoft) and includes a mix of ETFs across fixed income, core equity, and sector-specific funds. No period-over-period comparisons are available because this is a first-time 13F filing for the institution or the data is not presented in the filing.

  • · Top holdings by market value: Alphabet Class A ~$3.0M, Broadcom ~$3.0M, Palantir ~$3.2M, Apple ~$1.7M, Microsoft ~$1.8M.
  • · Largest position by shares owned: Pan American Silver Corp. (46,462 shares) valued at ~$2.4M.
  • · Portfolio includes significant ETF holdings, most notably iShares Silver Trust, SPDR Gold Trust, and Dimensional US Core Equity 2 ETF.
  • · Filing indicates no derivatives or put/call options held; all positions are common stock or ETF shares with sole voting/investment discretion.
HBT Financial, Inc. 8-K positive materiality 3/10

21-05-2026

HBT Financial, Inc. held its Annual Meeting of Stockholders on May 19, 2026, where all 12 director nominees were elected, executive compensation was approved in a non-binding advisory vote, and the appointment of RSM US LLP as independent auditor for 2026 was ratified. All proposals passed with strong shareholder support, though some directors received notable withhold votes, particularly Roger A. Baker with 4,435,074 votes withheld (15.1% of votes cast).

  • · Broker non-votes totaled 2,625,219 for all director elections and Proposals 1 and 2, but were zero for Proposal 3 (auditor ratification).
  • · The highest vote total for a director was Nancy L. Ruyle with 29,315,448 votes for, while the lowest was Roger A. Baker with 25,000,775 votes for.
  • · Proposal 2 (executive compensation) had 200,525 votes against and 188,854 abstentions.
  • · Proposal 3 (auditor ratification) had 37,991 votes against and 149,229 abstentions.
  • · The meeting was held on May 19, 2026, and the 8-K was filed on May 21, 2026.
FINANCIAL INSTITUTIONS INC 8-K positive materiality 4/10

21-05-2026

Financial Institutions, Inc. held its Annual Meeting on May 20, 2026, where shareholders elected five directors, approved the advisory Say-on-Pay proposal, and ratified the appointment of RSM US LLP as independent auditor for fiscal 2026. All proposals passed with strong support, though the Say-on-Pay vote saw 1.5 million shares against and 112,443 abstentions, indicating some shareholder dissent on executive compensation.

  • · Broker non-votes totaled 2,263,471 shares on all director elections and the Say-on-Pay proposal.
  • · The auditor ratification proposal had no broker non-votes; total votes cast were 17,701,370 (17,157,943 for, 522,914 against, 20,513 abstain).
  • · The lowest director approval was for Robert M. Glaser with 13,734,999 for and 1,702,900 withheld.
  • · The record date for the meeting was March 23, 2026, with 19,684,776 shares outstanding.
WEBSTER FINANCIAL CORP 425 neutral materiality 3/10

21-05-2026

Webster Financial Corporation provided an update on integration planning with Banco Santander, S.A. for its proposed acquisition, which is expected to close in the second half of 2026. The 'Walk the Walls' session involved teams from both organizations reviewing over 250 dependencies and 225 milestones, making nearly 100 updates to workplans, and holding three cross-functional breakout sessions. No financial metrics or performance data were disclosed in this communication.

  • · The acquisition is expected to close in the second half of 2026.
  • · The registration statement on Form F-4 was declared effective on April 22, 2026, and the definitive proxy statement/prospectus was mailed to Webster stockholders starting April 24, 2026.
  • · The communication does not constitute an offer or solicitation and includes extensive forward-looking statement disclaimers.

Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 32 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: S&P 500 Healthcare Sector SEC Filings

🇺🇸 More from United States

View all →